This inventor holds 14 USPTO granted patents and 2 published patent applications and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Eisai R&d Management Co., Ltd., Eisai Company, Limited, Epizyme, Inc.. Active years: 2001-2023.
IDiyas Innovation Intelligence. (2026). Inventor Profile: Wanjun Zheng. Retrieved from https://idiyas.com/inventor/wanjun-zheng
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Calculating rank
USPTO Granted Patents = 14 (Patent Applications = 2)
% Patents Active = 71.4
EPO Patents = 7 (Patent Applications = 4)
Average Co-Inventor Count = 6.9
ph-index = 6
Forward Citations = 333(Granted Patents)
Location History:
- Londonberry, NH (US) (2001)
- Londonderry, NH (US) (2002 - 2023)
Company Filing History:

Eisai R&d Management Co., Ltd.

Eisai Company, Limited

Epizyme, Inc.
4. 1 out of 1
Eisai R&d Co., Ltd.
Years Active: 2001-2023
Loading Chart...
Loading Chart...
Areas of Expertise:
Substituted Benzene Compounds
EP4 Antagonists
Deazapurines
Benzoxazole Compounds
Cancer Treatment
Macrocyclic Analogs
Intermediate Compounds
Preparation Methods
Compositions
Methods of Use
14 patents (USPTO):Explore Patents
Dear visitor, for article requests, kindly provide me with the title of the article you would like to have about inventor Wanjun Zheng, and I will craft the content for you following the outline you've provided.
Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents pending:
IDiyas Innovation Intelligence. (2026). Inventor Profile: Wanjun Zheng. Retrieved from https://idiyas.com/inventor/wanjun-zheng
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent pending (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
7 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents pending (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]